| Title |
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia |
| Scientific Title |
The Value of High Dose Versus Standard Dose ARA-C During Induction and of IL-2 After Intensive Consolidation/Autologous Stem Cell Transplantation in Patients (Age 15-60 Years) With Acute Myelogenous Leukemia. A Randomized Phase II Trial of the EORTC and the GIMEMA-ALWP |
| Short Title |
AML AraC-IL2 |
| Trialgroup |
EORTC |
| Type of Trial |
randomized |
| Disease |
Acute myeloic leukemia(AML) AML all subtypes without FAB M3
|
| Age |
Other 15-60 years |
| Status |
Active |
| Start of Recruitment |
01.09.1999 |
| Contactperson |
General Contact Person
Willemze, Prof. Dr. med., Roel
Email: r.willemze@lumc.nl
|
| Shortprotocol |
Shortprotocol |
created 